Clinical Trial Update: Effect of Antacids on the Pharmacokinetics of Raltegravir [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated whether antacids alter the pharmacokinetics of raltegravir in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: University of Colorado, Denver | Conditions: HIV Infections | Phase 1 | Status: COMPLETED